SOX2 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, OGT promotes tumor recurrence by modifying and stabilizing the transcription factor SOX2, while OSMI treatment markedly reduces the O‐GlcNAcylation level and stability of SOX2, thus decreasing recurrence [395].